Introduction
Gli1, a member of the Gli family of transcription factors, is a downstream effector of Hedgehog (Hh) signaling, which is critical for the control of development and cell proliferation (Ruiz i Altaba et al., 2002; Ingham and Placzek, 2006) . Constitutive activation of this pathway is responsible for several malignancies, including medulloblastoma (MB), the most frequent childhood brain tumor (Ruiz i Altaba et al., 2002) . In this context, Gli1 is a strong constitutive transcriptional activator whose expression is increased by Hh stimulation, thus providing a positive feedback mechanism. Gli1 also functions as an oncogene, as shown by its in vitro transforming ability (Ruppert et al., 1991; Canettieri et al., 2010) and by the reduced MB development in Gli1 (Goodrich et al., 1997; Kimura et al., 2005) . This emphasizes the relevance of the processes that control Gli1 oncogenic activity. In this regard, mechanisms affecting Gli protein ubiquitin (Ub)-dependent degradation are assumed to play a central role.
Ubiquitination is a post-translational modification that involves the action of different enzymes (E1, E2, E3 and E4) and terminates with the transfer of Ub to substrate proteins, which are thus targeted to the proteasome and degraded (Kerscher et al., 2006) . The major determinants of the ubiquitination mechanism are the E3 Ub ligases, classified into subfamilies: the two main classes belonging to the really interesting new gene (RING) or homologous to E6-AP C-terminus (HECT) families and the recently identified U-box (Hatakeyama et al., 2001) , PHD (Boname and Stevenson, 2001 ) and HUL-1 (Van Sant et al., 2001) , all known to bind specific degron sequences of the target proteins (Pickart, 2001; Welchman et al., 2005) .
Distinct E3 Ub ligases, belonging to the RING family, have been identified to be responsible for Drosophila and mammalian Ci/Gli proteolysis, through Hh-and phosphorylation-dependent regulation of Cullin1/b-TrCP and Cullin3/HIB-SPOP (Jia et al., 2005; Huntzicker et al., 2006; Zhang et al., 2006) . Although Cullin3-based events are critical for the control of Gli function during development, Cullin1/ b-TrCP-mediated degradation of Gli is also involved in tumor formation (Huntzicker et al., 2006) .
We have observed that reduced Gli1 ubiquitination, leading to its accumulation, occurs in human MB as a consequence of the loss of Numb (Di Marcotullio et al., 2006) . Numb is an evolutionarily conserved protein involved in cell fate determination, self-renewal and differentiation (Cayouette and Raff, 2002; Gulino et al., 2010) . Its modular structure confers a complex pattern of adaptor functions controlling endocytosis, cell adhesion, migration and ubiquitination of specific substrates (Gulino et al., 2010) . Instead of involving RING family E3 ligases, we reported that Numb-induced Gli1 ubiquitination and degradation is mediated by the HECT-type E3 Ub ligase Itch (Di Marcotullio et al., 2006) . Itch, also called AIP4 and, in Drosophila, Suppressor of Deltex, belongs to neuronal precursor cell-expressed developmentally downregulated 4 (NEDD4)/Rsp5p-like HECT family sharing a characteristic modular structure, with an N-terminal lipidinteracting C2 region, four WW protein-protein interacting motifs and a C-terminal catalytic HECT domain (Liu, 2004) . The mechanisms regulating the catalytic activity of the HECT E3 ligase are poorly investigated. Although our previous work suggests that the subversion of Gli1/Numb/Itch pathway plays a critical role in MB, how Numb enables Itch activation and how Itch targets Gli1 is not understood.
Here, we show that Numb functions as both a Gli1 recruiter and an activator of Itch. Through the binding to the WW domain, Numb releases Itch from its autoinhibitory intramolecular HECT/WW interaction, allowing the activated ligase to enhance its association with Gli1. We also show that Numb recruits Gli1 into the complex with Itch by directly binding the transcription factor. Gli1/Itch interaction is direct and mediated by two distinct Gli1-WW docking sites, which are both required to control Gli1 stability and oncogenic potential. These data identify a novel mechanism whereby Numb acts as a key factor in activating Itch function, highlighting the existence of a novel degron, which is critical for the Numb/Itch-modulated Gli1 activity.
Results

Numb activates the catalytic activity of Itch
We previously identified Numb as a component of Gli1-Itch Ub complex (Di Marcotullio et al., 2006) . However, the role of Numb in Itch-dependent regulation of Gli1 was not characterized. It has been shown that Itch is regulated by a conformational modification, in which the catalytic activity is kept inhibited by intramolecular binding of the HECT domain to a proline-rich and WW motifs containing region, a process relieved by stress-activated protein kinase cJun N-terminal protein kinase 1-mediated phosphorylation (Gallagher et al., 2006) . On the basis of the binding of only the Numb PTB domain to the WW1-2 region of Itch (McGill and McGlade, 2003) , we observed that Numb, but not NumbDPTB (a mutant deleted from 85 to 174 residues of the PTB domain), exclusively bound the WW2 motif of Itch (Figures 1a and b) . Therefore, we wondered whether the association of Numb could alter Itch intramolecular HECT interactions. To test this hypothesis, we evaluated the in vitro ability of recombinant HECT to bind immunoprecipitated Itch, in the presence or absence of Numb. Figure 1c confirms the in vitro binding of recombinant HECT to Itch (Gallagher et al., 2006) . In contrast, Numb prevented the binding between the HECT and WW region of Itch, whereas NumbDPTB was ineffective in displacing HECT (Figure 1c ). This result indicates that Numb destabilizes the intramolecular interaction of Itch, preventing its folding into an autoinhibitory state. Consistently, Numb enhanced the self-ubiquitination activity of Itch, whereas NumbDPTB did not (Figure 1d ). This mutant also displayed an inhibitory effect on Itch autoubiquitination at the highest dosage, suggesting a dominant-negative activity, possibly owing to interference with unidentified cofactors (Figure 1d ). Conversely, Numb failed to promote autoubiquitination of a catalytically inactive Itch mutant (C830A), thus indicating that the ubiquitination was self-induced ( Figure 1e ).
Overall, these findings indicate that Numb functions as an adaptor protein that, by binding Itch, releases it from self-inhibitory conformation, thus inducing its catalytic activity. This event also suggests that Numb promotes Gli1 ubiquitination by favoring Gli1 access to activated Itch.
Gli1 directly interacts with Itch via two distinct PPXY and phospho-serine/proline motifs The E3 ligases directly interact with both their substrates and E2 enzyme to facilitate the transfer of Ub onto the target proteins (Haas and Siepmann, 1997) . Thus, to verify the ability of Gli1 to interact with Itch, we carried out co-immunoprecipitation assays on endogenous proteins. Figure 2a reveals that Gli1 and Itch form a complex. Consistently, endogenous Gli1 ubiquitination and degradation were decreased or induced by depletion or ectopic expression of Itch, respectively, further supporting the relevance of Gli/Itch association . This evidence was further confirmed by the ability of Itch to induce ubiquitination of Gli1 in an in vitro system reconstituted with purified components (Supplementary Figure S1d) . These observations strongly suggest that Itch is a physiological Ub E3 ligase for Gli1.
The WW domains of Itch are known to mediate the binding to several target proteins (Qiu et al., 2000; Courbard et al., 2002; Fang et al., 2002; Traweger et al., 2002; Ikeda et al., 2003; Magnifico et al., 2003; Chang et al., 2006; Mouchantaf et al., 2006) . To test whether Gli1 binds Itch by WW domains, we carried out a pulldown assay. A glutathione S-transferase (GST) fusion protein containing the small region of Itch with all four WW domains (GST-WWs) showed specific interaction with Gli1 (Figure 2b ). Among the four WW sites, Gli1 binds WW1, -2 and -4, but not WW3 (Figure 2c) .
To map the Itch-binding and -responsive sites in Gli1, we investigated a series of Gli1 mutants. Figure S2d) . These observations suggest that Itch activity on Gli1 is independent of degrons D N and D C and imply that an additional degron is responsible for Gli1 interaction and stability via an Itch-dependent pathway. Therefore, to identify the Itch-binding site in Gli1 protein, we performed in vitro binding experiments. GST-pull-down assays showed that only the full-length Gli1 and two deletion constructs including the C-terminal region (Gli1 and Gli1 ) bound GST-Itch, whereas the aa 2-234, 2-413 and 424-755 regions of Gli1 did not interact (Figure 2d ). The in vitro association was also confirmed by in vivo co-immunoprecipitation assay (Figure 2e ). These results indicate that the region between 755 and 1106 aa of Gli1 is necessary for Itch interaction.
The WW domains mediate ligase-substrate associations through the interaction with a variety of prolinerich motifs (Ingham et al., 2004) . Typically, PPXY or pSP (proline residues preceded by phosphoserine) motifs have been reported to be docking sites for several WW domain containing E3 ligases of the NEDD4 family (Sudol, 1996; Espanel and Sudol, 1999; Lu et al., 1999; Bedford et al., 2000; Macias et al., 2002; Rossi et al., 2005; Sudol et al., 2005) . Gli1 contains two PPXY motifs in its C-terminal tail, in the region spanning aa 755-1106. To test whether these domains are involved in Gli1-Itch association, we disrupted both binding consensus sequences by replacing tyrosine (Y) with phenylalanine (F) at residues 859 and 872 of full-length Gli1 (Gli1 PPXY/F ). Surprisingly, we found that these mutations did not affect significantly Itch-binding ability (Figure 2f ), suggesting that the interaction of Gli1 and Itch may require additional elements. Therefore, we mutated a pSP motif of Gli1 by replacing serine 1060 with alanine. As shown in Figure 2f , while this mutant alone (Gli1 pS1060A ) still interacted with Itch, Gli1 mutated in both PPXY and pS 1060 P motifs (Gli1 triple mutant, Gli1 TM ) failed to bind Itch. These results indicate that the combination of two intact PPXYs motifs and pS 1060 P represent the specific Itch-binding site of Gli1.
PPXYs/pSP degron is required for Itch-dependent ubiquitination of Gli1 To identify the Gli1 domain ubiquitinated by Itch, we next performed ubiquitination assays on either the Nterminal (aa 2-413) or the C-terminal (aa 424-1106) regions of Gli1. As show in Figure 3a and Supplementary Figure S3 , the C-terminal domain and Gli1 fulllength, as well as Gli1 deleted of both degrons D N and D C (Gli1D398DD C ) were efficiently ubiquitinated by ectopic Itch, whereas the N-terminal region (Gli1 2À413 ) or A novel degradation signal in Gli1 protein L Di Marcotullio et al
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424À755 mutants were not affected. This result indicates that Gli1 C-terminus serves as substrate for Itch Ub conjugation and that the 755-1106 region is required for both recognition and subsequent ubiquitination by Itch.
In keeping with binding data described above, Gli1 proteins mutated in either C-terminal PPXYs or pSP, which showed interaction with Itch, were still efficiently ubiquitinated by this E3 ligase, whereas Gli1 mutated in Itch total lysate
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Itch impairs Gli1 transcriptional activity promoting its degradation
The ability of Itch to induce Gli1 ubiquitination implies an antagonistic role on the functional activity of this transcription factor. To correlate these observations with the transactivating function of Gli1, we tested two types of fusion proteins: the N-terminal region of Gli1, containing the DNA-binding domain, fused to the VP16 transactivation domain (Gli1N-VP16) and two different C-terminal regions of Gli1 fused to the Gal4 DNAbinding domain (Gal4-Gli1 C-700 , 424-1106 aa; Gal4-Gli1 C-400 , 755-1106 aa) (Figure 4a ). In keeping with its ability to ubiquitinate only Gal4-Gli1 C-400 protein, but not Gli1N-VP16 (Supplementary Figure S3e) , Itch failed to inhibit the activity of transfected Gli1N-VP16 fusion protein over a Gli-luciferase reporter, showing that the N-terminus is not subjected to Itch-mediated regulation (Figure 4b ). By contrast, the activity of Gal4-Gli1C fusion proteins over a Gal4 reporter was potently inhibited by co-transfected Itch (Figure 4b) , confirming that the Itch-responsive site of Gli1 is functionally located on the C-terminus. In accordance with these results, Itch overexpression significantly decreased the transcriptional activity of Gli1 full-length and Gli1 deleted of D N and D C degrons, whereas its inhibiting effect was strongly reduced in Gli1 TM (Figure 4c and Supplementary Figure S3b) , indicating that the functional regulation of Gli1 is determined by PPXY-and pS 1060 P-dependent interaction with Itch. On the basis of the insensitivity of Gli1 TM to Itch antagonist effects (for example, ubiquitination, transcriptional activity), we investigated the stability of this mutant. We first measured protein levels in whole-cell extracts in the presence of increasing amount of Itch. Co-expression of Itch induces a decrease of Gli1 wildtype levels, but not of Gli1 TM , indicating that this mutant is not a target for Itch-dependent degradation (Figure 4d ). This is confirmed by the increased half-life of Gli1 TM with respect to wild-type protein, evaluated by cycloheximide blockade (Figure 4e ). Taken together, our findings show that PPXYs and pS 1060 P motifs represent a novel C-terminal degron that regulates Gli1 transcriptional function by influencing its stability via a dedicated Itch-dependent pathway.
Numb recruits Gli1 onto the activated Itch complex
To determine whether and how Numb, in addition to activating Itch function, interacts with Gli1, we first performed GST-pull-down assay, which showed that Numb binds Gli1 directly (Figure 5a ) and that the Gli1 region spanning aa 228-755 is involved in this interaction (Supplementary Figure S4) .
To identify a Numb mutant able to interact with Gli1 but not with Itch, we tested the binding of Numb deletion mutants with Gli1 (Figures 5b-e) . All mutants (keeping the region 85-174 aa required for Itch interaction) bound Gli1, probably owing to the bridge effect of endogenous Itch, which binds both Gli1 and Numb (Figure 5c ). To rule out the bridging effect of endogenous Itch, we tested the binding of Numb deletion mutants to Gli1 TM . All Numb mutants bound WT or FlagGli1 mutants (Gli1 PPXY/F , Gli1 pS1060A and Gli1 TM ) were co-transfected with HA-Ub in the presence or absence of Myc-Itch. Ubiquitination assay was determined as described in (a).
, with the exception of NumbD174-421, suggesting that the 174-421 aa region is required to bind directly Gli1 (Figure 5d ). Accordingly, NumbD85-421 mutant, deleted of both the Itch-(85-174 aa) and Gli1-(174-421 aa) interacting regions, was unable to bind Gli1 wild-type, whereas NumbD174-421 did (Figure 5e) .
Interestingly, by co-immunoprecipitation experiments with Gli1 and Itch, we found that NumbDPTB, which no longer binds Itch and fails to inhibits Gli1 activity (Di Marcotullio et al., 2006) , also showed an impaired interaction with Gli1 with respect to wild-type Numb (Figure 5f ). This suggests that the interaction among the three proteins is required to stabilize the whole complex and that Numb, in addition to activating Itch, also recruits Gli1.
Itch-dependent degron is required for the cofactor role of Numb in Gli1 ubiquitination
To determine the functional role of Numb/Gli1 interaction, we tested the effect of the above described Numb mutants on Gli1 ubiquitination. In keeping with its inability to bind Gli1, D174-421 Numb mutant displayed lower Gli1 ubiquitination activity compared with wild-type Numb (Figure 5g ). These findings indicate that the Numb-mediated recruitment of Gli1 into the complex with Itch provides a substantial contribution to drive ubiquitination.
We further investigated whether the newly identified (PPXP/pSP) degron is also essential for the activity of Numb. Accordingly, Numb was unable to ubiquitinate the Itch-insensitive Gli1 TM mutant, while strongly active upon wild-type Gli1 (Figure 5h) . Similarly, Numb Itch impairs Gli1 transcriptional activity promoting its degradation. (a) Schematic representation of Gli1 and subdomains used to generate the Gli1N-terminal VP16 and Gal4 C-terminal fusion proteins and reporters. Gli1 (2À424 aa) fragment was fused to VP16 transactivation domain (Gli1N-VP16); Gli1 (755À1106 aa) (C-400) or (424À1106 aa) (C-700) fragments were fused to the Gal4 DNA-binding domain. (b) Luciferase assay was performed in HEK293 cells transfected with: Gli1N-VP16 and 12 Â Gli Luc reporter, alone or in combination with Itch (on the left) or with Gal4-Gli1 C-400 or Gal4-Gli1 C-700 and Gal4-responsive luciferase reporter, in the absence or presence of Itch (on the right). *Gal4-Gli1 C-400 þ Itch vs Gal4-Gli1 WT vs Gli1 TM in the presence of increasing amount of Itch (0.5, 1 or 2 mg) (d) or after treatment with 30 mg/ml of cycloheximide (CHX) for the indicated time points (e). The graph represents the amount of Gli1 from each transfection normalized to the amount at the initiation of CHX treatment.
A novel degradation signal in Gli1 protein L Di Marcotullio et al synergizes with ectopic Itch for Gli1 ubiquitination, whereas NumbDPTB, which no longer binds Itch, does not (Supplementary Figure S5) , confirming previous observations (Di Marcotullio et al., 2006) and mirroring its effect on Itch autoubiquitination (Figure 1d ). These findings suggest not only the specificity of Numb activity, but also that the interaction of Itch with the PPXY/pSP motifs is required for Numb action. Overall, these findings indicate that Numb functions as an adaptor protein that, by binding both Gli1 and Itch, promotes Gli1 ubiquitination.
Itch-dependent degron is required for the control of the oncogenic properties of Gli1
Loss of expression of Numb in MBs and its inhibitory activity upon the oncogenic Hh/Gli1 pathway suggest an oncosuppressor function for this protein (Di Marcotullio et al., 2006). Indeed, hyperactive Hh pathway is responsible for cerebellar tumorigenesis and ectopic expression of Gli1 increases the proliferation of MB cells (Galvin et al., 2008) . To link the oncogenic function of Gli1 to the PPXY/pSP/Itch-dependent pathway and to determine the role of Numb in this context, we analyzed WT or Gli1 TM were transfected in HEK293 cells with HA-Ub in the absence or presence of Numb wild-type or NumbDPTB. Ubiquitination assay was determined as described in (g).
proliferation by bromodeoxyuridine incorporation in D283 cells, an Hh/Gli-dependent responsive MB cell line (Bar et al., 2007) . Wild-type Gli1 enhanced the proliferation rate, which was inhibited by Numb overexpression, but not by NumbDPTB mutant (Figure 6a ). In contrast, Gli1 TM mutant increased the proliferation rate to a higher extent than wild-type Gli1, which was no longer affected by Numb (Figure 6a ). These results indicate that Gli1-PPXYs and pSP motifs are functionally relevant and show the specificity of the Itch role in Numb-induced effect on Gli1 function in controlling tumor growth. Consistently, we observed that ectopic expression of Gli1 TM mutant enhanced the adhesionindependent growth of D283 cells, compared with Gli1 WT , as assessed by the increased size and number of colonies grown in soft agar (Figure 6b and Supplementary Figure S6a) . Remarkably, Numb or Itch inhibited the colony formation ability of D283 cells, whereas NumbDPTB mutant or the inactive ItchC830A were ineffective (Figure 6b ). In keeping with the specific role of Numb and Itch on PPXY/pSP degron, Gli TM was insensitive to all these proteins (Figure 6b ).
Additional features of malignancy (that is, migration and invasion potential) were also affected by Gli1 TM mutant in Daoy, a metastatic MB cell line (MacDonald et al., 2001) . In a Transwell assay, Gli1 TM overexpression significantly increased the ability of Daoy cells to migrate through a porous membrane (Figure 6c ) or to invade through the Matrigel (Figure 6d ), compared with Gli1 WT , thus highlighting the importance of Itch-degron in regulating cancer cell migration and invasion.
Finally, to study whether mutations in Itch-degron are relevant for cell transformation, we performed a focus formation assay in rat kidney RK3E cells, in which ectopic expression of Gli1 or activated Ras oncogene induce foci formation (Figure 6e) (Ruppert et al., 1991; Canettieri et al., 2010) . As shown in Figure 6e TM mutant on cell migration and invasion. Daoy cells were transfected with specific plasmids and allowed to migrate through a porous membrane (c) and to invade through Matrigel (d). Results represent the average from multiple fields of three independent experiments. *WT vs empty, Po0.01; **TM vs WT, Po0.01. (e) Effect of Gli1 TM mutant on focus formation assay. RK3E cells were transfected with the specific plasmids. After 3 weeks, cells were fixed, stained with crystal violet and scored for foci formation. Representative pictures of the focus formation assay and the relative number of foci formed are shown. Results represent the average of three independent experiments, each performed in duplicate. *WT and Ras vs empty, Po0.01; **TM vs WT, Po0.01.
with wild-type protein, indicating that alterations in Itch degron enhance Gli1 in vitro oncogenic activity. Interestingly, the in vitro transforming activity of Gli1 TM mutant was similar to that one of Gli1DD C deleted of the b-TrCP-dependent site (Supplementary Figure S6b) , indicating that both Cul1/b-TrCP and Itch degradation pathways influence to the same extent the oncogenic property of Gli1. In addition to Gli1, Itch is involved in the regulation of c-Jun and other targets . Recently, a cooperation between c-Jun and Gli1 has been described in human keratinocytes, in which Hh enhances the expression of c-Jun, thus synergizing with it for cell cycle progression (Laner-Plamberger et al., 2009) . To rule out the possibility that c-Jun regulates MB growth by targeting AP-1, we tested whether a cross-talk between Gli1 and c-Jun also exists in MB cells. In contrast with findings in keratinocytes, a doseresponse curve of Gli1 overexpression in Daoy cells did not increase the levels of c-Jun (Supplementary Figure  S7) . Consistently, Gli1 overexpression did not activate the transcription from a Jun-responsive MMP1-luciferase reporter (Supplementary Figure S7) , a c-Jun target (Canettieri et al., 2009 ). c-Jun was not either regulated by Itch in Daoy cells, as short interfering RNA (siRNA)-mediated depletion of Itch did not influence c-Jun levels (Supplementary Figure S7) . These observations suggest that no functional interactions among c-Jun, Gli and Itch occur in MB cells.
Overall, our findings show that mutations in Itchdegron induce accumulation of Gli1 and suggest that the integrity of these modules is important to prevent in vitro transformation and tumor cell growth.
Discussion
In this work, we identify a novel molecular mechanism of Numb-induced regulation of the HECT ligase Itch to promote Gli1 ubiquitination. We showed that Numb, by binding the WW2 site of Itch, displaces the HECT domain from its interaction with the WW region, thereby releasing its inhibitory state and enhancing its catalytic activity (Figure 7) . Such an autoinhibitory intramolecular interaction has been shown to be impaired by c-Jun N-terminal protein kinase-induced phosphorylation of the proline-rich/WW region of Itch (Gallagher et al., 2006) . Our findings support the general view that Itch and other HECT E3 ligases, in addition to phosphorylation events, are activated by interaction with adaptor molecules (that is, Numb and NDFIP) that disrupt its self-inhibitory conformation (this study and Mund and Pelham, 2009) . Thus, by activating Itch, Numb allows Gli1 access and, through direct interaction, recruits Gli1, thus reinforcing the complex formation. Importantly, a Gli1/Itch direct association is also needed to induce substrate ubiquitination: this involves the binding of two distinct WW docking sites (PPXY and pSP) of Gli1, thus identifying a novel degron (Figure 7) . Abrogation of all these sites is required to impair Numb-enhanced Itch activity, indicating that they function in concert to target Gli1 protein for ubiquitination and degradation.
Although PPXY motifs have been previously reported to mediate Itch activity upon substrates (Fang and Kerppola, 2004; Rossi et al., 2005; Omerovic et al., 2007; Shembade et al., 2008) , the results described here are the first evidence that a pSP module is also required for Itch to interact with its target and to perform its essential function. The ability of Itch to interact with two distinct WW-binding domains is reminiscent of the degradation mechanism of NEDD4, another HECT ligase, whose WW domains interact with either PPXY and pSP motifs (Bedford et al., 2000) .
Our findings add further complexity to the Gli proteins regulation by Ub-dependent events. Indeed, downregulation of the Cullin1-based ubiquitination of Gli1 is a part of an Hh-induced activator signal by which Hh maintains a low degradative pathway to enable Gli function (Huntzicker et al., 2006) . Conversely, the adaptor protein HIB/SPOP is upregulated by Hh, thus promoting Gli degradation by Cullin3-based ubiquitination and representing an Hh-induced negative feedback loop to modulate the signaling response (Zhang et al., 2006) . We have described a novel E3 ligase-dependent mechanism suppressing Gli1 function, mediated by Itch, which unveils a novel regulatory process sustained by the developmental protein Numb.
Our observations may have important implications for cell development and tumorigenesis, owing to the strong oncogenic properties of Hh/Gli1. Numb is a major determinant of asymmetric cell division, thereby controlling stem/progenitor cell fate (Gulino et al., 2010) . We have identified a novel function of Numb, as a protein adapting cell developmental process to E3 Ub ligase pathway through the suppression of Hh-dependent signals. Such a role of Numb as an Itch activator might occur for other Itch substrates such as Notch, which is also negatively regulated by Numb, thus highlighting a common ligase-dependent molecular mechanism for Numb in the control of developmental signaling pathways frequently subverted in tumorigenesis (Gulino et al., 2010) .
Although preliminary investigation failed to identify defective Gli1 mutants insensitive to Itch in MBs, a subversion of Itch-dependent control of Gli1 has been described in this tumor. Indeed, the downregulated expression of Numb, observed in MB, leads to a reduced Itch-dependent ubiquitination of Gli1 and its accumulation in cancer cells (Di Marcotullio et al., 2006) .
Consistent with the relevance of such a process in cancer, our data suggest a model (Figure 7 ) that illustrates how Itch destruction signal prevent Gli1 protein accumulation. Mutations on this degron, by inducing Gli1 stability, lead to an increased proliferation rate of MB cells, anchorage-independent tumor growth, an higher capacity of migration and invasion of MB cells, thereby highlighting a tumor-promoting role. Accordingly, expression of Gli1 Itch-degron mutant triggered a significantly higher neoplastic transformation of rat kidney cells in vitro. For this reason, targeted therapies that prevent Gli1 accumulation may have potent antitumor properties.
Itch targets a number of proteins involved in tumorigenesis (Jun, p73, p63, Notch and Gli1), providing a strong rationale for a possible role of Itch misregulation in cancer, as discussed recently (Bernassola et al., 2008; Melino et al., 2008; this study) . Although spontaneous tumors in human cases of Itch deficiency and in Itch mutant mice (Itchy mice) have not yet been reported (Perry et al., 1998; Lohr et al., 2010) , no systematic studies have been undertaken to correlate Itch ablation with tumor development. Therefore, the Itch involvement in tumorigenesis remains unclear and needs to be further investigated. In this respect, it must be remembered that the life span of Itch-deficient mice is shortened by severe immune and inflammatory defects, making the observation of a tumor phenotype difficult and requiring additional investigation in different genetic backgrounds. However, the emerging number of Itch target proteins implicated in cancer might result in an unbalanced control of tumorigenesis, depending on the main oncogene addiction occurring in specific tumor context, an hypothesis that might be addressed by investigating the effect of a conditional Itchy mutation in a Ptc1 þ /À MB prone background in future studies.
Materials and methods
Plasmids
The following plasmids were kindly provided by other labs: pCS2-HA3-Gli1 WT , -Gli1DD C , -Gli1DD N , Gli1D398 and -Gli1D398DD C mutants (A Oro), pcDNA-Myc-Itch, -FlagItch, -Flag-C830A and GST-Itch (M Alimandi), 12 Â Gli-Luc (R Toftgard) and pcDNA-Flag-Numb (L D'Adamio). Different Flag-Gli1 and Flag-Numb mutants were generated with standard cloning techniques. Gli1 PPXYs/F, S1060A and Gli1 TM were generated using the QuickChange site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA) and verified by sequencing.
Antibodies
Anti-Gli1 (sc-20687; sc-6152), anti-hemagglutinin (HA) (sc-7392), anti-Myc (sc-40AC), anti-actin (sc-1616), anti-green fluorescent protein (sc-8334; sc-9996) and anti-GST (sc-138S) were purchased from Santa Cruz Biotechnology, Heidelberg, Germany; anti-Flag (M2) from Sigma (St Louis, MO, USA); and anti-Itch from BD Bioscience, San Jose, CA, USA.
Cell culture and transfections NIH3T3, human embryonic kidney 293 (HEK293), D283 and Daoy cells were cultured in Dulbecco's modified Eagle's medium containing 10% bovine or fetal bovine serum, penicillin and streptomycin. The cells were transfected using Lipofectamine 2000 or Lipofectamine Plus (Invitrogen, Milan, Ialy). For RNA interference, scrambled or Itch short interfering RNA oligos (Dharmacon, Inc., Lafayette, CO, USA) were transfected for 48 h, using Hyperfect Reagent (Qiagen, Milian Italy). Luciferase activity was assayed with a dual luciferase assay system (Promega, Milian, Italy) as described previously by Di Marcotullio et al. (2004) . All luciferase activity data are presented as means±s.d. of values from at least three experiments, each performed in triplicate.
Immunoblotting, immunoprecipitation and ubiquitination assay Transfected cells were lysed in 50 mM Tris-HCl (pH 7.6), 150 mM NaCl, 1% NP-40 and protease inhibitors. For immunoblotting, protein extract was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Immunoprecipitation and in vivo ubiquitination assays were carried out as described previously (Di 
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Numb Numb Figure 7 Model of the Numb/Itch-dependent regulation of Gli1 activity. Numb binds WW2 domain of Itch, which is released from its self-inhibitory intramolecular interactions between HECT and WW domains, thereby recruiting Gli1 and stabilizing its association to the complex. In turn, the WW domains of Itch bind the PPXYs and pSP docking sites on Gli1 C-terminus, resulting in protein ubiquitination and proteasomal-dependent degradation. This process impairs the enhancing activity of Gli1 upon MB cell growth, suggesting its involvement in the control of tumorigenesis.
A novel degradation signal in Gli1 protein L Di Marcotullio et al transfection with expression plasmid for HA-Ub in combination with the indicated plasmids, cells were lysed in denaturating radio immunoprecipitation assay buffer. Total lysates were subjected to immunoprecipitation with indicated antibodies. Polyubiquitinated species were detected using anti-HA antibody.
GST-pull-down assay GST recombinant proteins were bound to glutathione beads (GE Healthcare, Amersham, Milan, Italy) and incubated for 1 h with in vitro translated protein or lysates of transfected cells in binding buffer (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 20 mM, MgCl 2 2 mM, KCl 100 mM, 20% glycerol, EDTA 0.2 mM, 0.05% NP40) and analyzed by fluorography or immunoblotting.
Cell proliferation, colony formation, focus formation, migration and invasion assays Cell proliferation was evaluated by bromodeoxyuridine incorporation (12 h pulse for D283), as described previously by Argenti et al. (2005) . For anchorage-independent growth in soft agar assay, 1 Â 10 5 D283-transfected cells were suspended in culture medium containing 0.3% agarose and plated over a layer of 0.7% agarose in the same culture medium. At 14 days after plating, colonies of 400 cells were scored in 10 representative fields in each plate. Focus formation assay was performed as described previously (Canettieri et al., 2009) . All assays were performed in triplicate and results shown are the average of three independent experiments. Migration of MB cells through membranes was assessed using Transwell filter inserts assembled in a 24-well plate (Costar, Bethesda, MD, USA); invasion was assayed using insert membranes coated with the Matrigel (BD Bioscience) (Guerreiro et al., 2008) . The percent invasion was determined according to the manufacturer's instruction.
